Pfizer has unveiled its new research and development centre in Beijing, marking a significant step in the company's strategic expansion in China.

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

The U.S., once a leader in diverse clinical trials, is reversing its initiatives under the Trump administration, causing ...

“We are grateful to Pfizer for their visionary support of UC San Diego Moores Cancer Center to develop and implement this ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE – Research Report), Nanobiotix (NBTX – Research ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point.

“We are grateful to Pfizer for their visionary ... novel program,” said Vice Chancellor for Health Sciences Dr. John M. Carethers. “This initiative is designed to address the unequal burden ...